RT Journal
A1 Gaziano J, Gaziano TA
T1 SImplifying the approach to the management of dyslipidemia
JF JAMA
JO JAMA
YR 2009
FD November 18
VO 302
IS 19
SP 2148
OP 2149
DO 10.1001/jama.2009.1685
UL http://dx.doi.org/10.1001/jama.2009.1685
AB 
In this issue of JAMA, Kuklina and colleagues1 report trends over the last decade in cholesterol levels and treatment. While the decreasing prevalence of “high” low-density lipoprotein cholesterol (LDL-C) levels and increasing use of lipid-lowering medications in appropriate individuals are encouraging, the most sobering message in this article is the disappointing rates of screening, awareness, and treatment. Among those with high LDL-C levels, one-third had not been screened, and one-fourth were unaware that their levels were high. About two-thirds of those who were high risk were not receiving medication, although the vast majority of these individuals would likely benefit from lipid-lowering therapy.